Continuation of Drug Supply in Chinese Patients After CAMN107DBR01study Termination

NCT01613053 · clinicaltrials.gov ↗
NO_LONGER_AVAILABLE
Status
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Novartis Pharmaceuticals